<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00548288</url>
  </required_header>
  <id_info>
    <org_study_id>PAM19382CE</org_study_id>
    <nct_id>NCT00548288</nct_id>
  </id_info>
  <brief_title>Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty</brief_title>
  <official_title>Phase 1 Study of the Effect of Local Pamidronate Application in Preventing Periprosthetic Bone Loss After Total Cemented Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General and Teaching Hospital Celje</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General and Teaching Hospital Celje</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study are to determine whether pamidronate applied locally causes diminished
      periprosthetic bone loss and decreased rate of bone turnover compared to patients receiving
      placebo after cemented total hip arthroplasty (THA). The study design will be prospective,
      randomized, and blind. Periprosthetic bone mineral density (BMD) will be measured with dual
      energy X-ray absorptiometry (DXA) at the total periprosthetic area as well as at seven Gruen
      zones or regions of interest. DXA scans will be performed at one week (baseline), three
      months, and six months postoperatively. Mean values of biochemical markers of bone turnover,
      BMD, and baseline-normalized BMD values will be compared between the bisphosphonate and
      placebo groups at each time point. For all temporal measurements including bone markers, BMD
      and normalized BMD, mean values will be compared across each time point within a given group.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2007</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Periprosthetic bone mineral density</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical markers of bone turnover</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Arthroplasty</condition>
  <condition>Mineral Density</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pamidronate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with hip arthritis scheduled for total cemented hip arthroplasty

        Exclusion Criteria:

          -  pregnancy

          -  endoprosthesis on contralateral hip
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samo K Fokter, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General and Teaching Hospital Celje</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samo K Fokter, MD, PhD</last_name>
    <phone>+38634233306</phone>
    <email>samo.fokter@guest.arnes.si</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department for Orthopaedic Surgery and Sports Trauma, Celje Teaching Hospital</name>
      <address>
        <city>Celje</city>
        <zip>3000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2007</study_first_submitted>
  <study_first_submitted_qc>October 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2007</study_first_posted>
  <last_update_submitted>October 22, 2007</last_update_submitted>
  <last_update_submitted_qc>October 22, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2007</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

